Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 1001-1050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05877885
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
NARecruiting
84 participants
Started: Sep 19, 2025 · Completed: Dec 1, 2028
2 conditions2 sponsors1 location
NCT07011654
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
PHASE1/PHASE2Recruiting
31 participants
Started: Sep 19, 2025 · Completed: Jul 1, 2030
1 condition2 sponsors1 location
NCT06919744
Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase
NARecruiting
114 participants
Started: Sep 19, 2025 · Completed: Apr 30, 2029
1 condition2 sponsors3 locations
NCT07162194
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
NARecruiting
130 participants
Started: Sep 19, 2025 · Completed: Oct 15, 2028
1 condition2 sponsors1 location
NCT07167433
Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
N/ARecruiting
250 participants
Started: Sep 19, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT07206628
Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®
N/ARecruiting
200 participants
Started: Sep 19, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor15 locations
NCT07207096
Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.
N/ARecruiting
100 participants
Started: Sep 19, 2025 · Completed: Aug 31, 2027
2 conditions3 sponsors1 location
NCT07025551
A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)
PHASE1Recruiting
18 participants
Started: Sep 19, 2025 · Completed: Jan 7, 2026
2 conditions1 sponsor1 location
NCT07072988
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
PHASE4Recruiting
50 participants
Started: Sep 19, 2025 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT07083076
Regular Diet Versus Extended Low Residue After Colon Surgery
NARecruiting
222 participants
Started: Sep 19, 2025 · Completed: Jul 1, 2028
1 condition1 sponsor2 locations
NCT06995833
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
N/ARecruiting
50 participants
Started: Sep 19, 2025 · Completed: Jun 29, 2029
1 condition1 sponsor1 location
NCT07194837
The Efficiency of 810 nm Diode Laser on Periapical Healing After Root Canal Retreatment
NARecruiting
40 participants
Started: Sep 19, 2025 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT07065929
Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke
NARecruiting
3,084 participants
Started: Sep 19, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor12 locations
NCT06794983
Calls and Coordination for Transitions of Care at Re-entry
NARecruiting
488 participants
Started: Sep 19, 2025 · Completed: Oct 1, 2028
5 conditions2 sponsors1 location
NCT07075523
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
N/ARecruiting
36 participants
Started: Sep 19, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06946797
A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
76 participants
Started: Sep 19, 2025 · Completed: Oct 25, 2028
1 condition1 sponsor50 locations
NCT07015437
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
PHASE2Recruiting
70 participants
Started: Sep 19, 2025 · Completed: Oct 15, 2026
1 condition1 sponsor2 locations
NCT07182097
Fentanyl vs. Remifentanil in Laparoscopic Cholecystectomy: Effects on Bowel Function and Pain
NARecruiting
106 participants
Started: Sep 19, 2025 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT07171281
Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes
NARecruiting
30 participants
Started: Sep 19, 2025 · Completed: Feb 28, 2028
3 conditions7 sponsors1 location
NCT07212283
Wise Intervention for Reducing Aggressive Behaviors and Promoting Prosocial Behaviors Toward LGB-TNB Individuals
NARecruiting
1,000 participants
Started: Sep 18, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06619106
Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study
N/ARecruiting
100 participants
Started: Sep 18, 2025 · Completed: Sep 18, 2027
1 condition1 sponsor1 location
NCT07184242
Strength Training and Proprioceptive Stimulation on Pain, Function, Quality of Life, Sleep Quality, and Psychosocial Factors in Older Adults With Shoulder Pain
NARecruiting
80 participants
Started: Sep 18, 2025 · Completed: Dec 19, 2025
1 condition1 sponsor1 location
NCT07165015
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
PHASE1Recruiting
32 participants
Started: Sep 18, 2025 · Completed: Mar 31, 2026
4 conditions1 sponsor4 locations
NCT07124000
DESTINY-PANTUMOUR04
N/ARecruiting
100 participants
Started: Sep 18, 2025 · Completed: Mar 30, 2028
27 conditions1 sponsor8 locations
NCT07085572
Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer
PHASE2Recruiting
31 participants
Started: Sep 18, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT07196735
Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia
N/ARecruiting
40 participants
Started: Sep 18, 2025 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT06742385
Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases
NARecruiting
290 participants
Started: Sep 18, 2025 · Completed: Sep 18, 2028
2 conditions3 sponsors1 location
NCT06497465
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
PHASE3Recruiting
150 participants
Started: Sep 18, 2025 · Completed: Jan 31, 2029
2 conditions2 sponsors6 locations
NCT07151235
Wildfire Related Air Pollution Exposure and Cognitive Function Pilot Study
NARecruiting
10 participants
Started: Sep 18, 2025 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT07197398
Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section
N/ARecruiting
140 participants
Started: Sep 18, 2025 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT07089745
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
NARecruiting
30 participants
Started: Sep 18, 2025 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT07199270
A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult
PHASE1Recruiting
64 participants
Started: Sep 18, 2025 · Completed: Dec 16, 2026
1 condition1 sponsor1 location
NCT07198035
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
PHASE1Recruiting
12 participants
Started: Sep 18, 2025 · Completed: Dec 26, 2025
1 condition1 sponsor1 location
NCT05826223
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
N/ARecruiting
1,200 participants
Started: Sep 18, 2025 · Completed: Jan 31, 2026
1 condition2 sponsors4 locations
NCT06789406
PMCF Study of the Axonics SNM System Model 5101 (R20)
NARecruiting
55 participants
Started: Sep 18, 2025 · Completed: Oct 31, 2031
3 conditions1 sponsor2 locations
NCT06788444
Efficacy of Esketamine for Patients With Irritable Bowel Syndrome
NARecruiting
552 participants
Started: Sep 18, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT07187596
Mortality Outcome of Controlled Hypertension
N/ARecruiting
1,000,000 participants
Started: Sep 18, 2025 · Completed: Apr 14, 2026
11 conditions1 sponsor1 location
NCT06848842
Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
PHASE2Recruiting
40 participants
Started: Sep 18, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT07172438
A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers
NARecruiting
1,950 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor27 locations
NCT06847399
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
PHASE2Recruiting
105 participants
Started: Sep 17, 2025 · Completed: Dec 1, 2027
2 conditions2 sponsors1 location
NCT07158151
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
PHASE2Recruiting
168 participants
Started: Sep 17, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06325202
Closed Loop and Education for Hypoglycemia Awareness Restoration
NARecruiting
324 participants
Started: Sep 17, 2025 · Completed: Jul 31, 2028
1 condition11 sponsors8 locations
NCT06682780
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
PHASE1/PHASE2Recruiting
320 participants
Started: Sep 17, 2025 · Completed: Dec 1, 2029
1 condition1 sponsor1 location
NCT07192185
Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab
PHASE2Recruiting
30 participants
Started: Sep 17, 2025 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT06500845
Assessment of Marginal and Internal Fit of High Performance Polymer PEEK Endocrown Using Two Preparation Designs
NARecruiting
24 participants
Started: Sep 17, 2025 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT07053891
LUPKYNIS Drug-use Results Survey
N/ARecruiting
400 participants
Started: Sep 17, 2025 · Completed: Jun 30, 2032
1 condition1 sponsor1 location
NCT06928116
Heat thErapy And mobiLity in COVID-19 Survivors
NARecruiting
99 participants
Started: Sep 17, 2025 · Completed: Aug 31, 2029
1 condition2 sponsors1 location
NCT07118241
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
PHASE2Recruiting
80 participants
Started: Sep 17, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor6 locations
NCT07162922
Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomy
NARecruiting
76 participants
Started: Sep 17, 2025 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT07110519
Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
EARLY_PHASE1Recruiting
10 participants
Started: Sep 17, 2025 · Completed: May 31, 2027
1 condition1 sponsor1 location